Intra-cellular Therapies share price today
(ITCI)
Intra-cellular Therapies share price is $84 & ₹7,147.98 as on 24 Dec 2024, 2.30 'hrs' IST
$84
▲
0.55
(0.66%)
Market is closed - opens 8 PM, 24 Dec 2024
View live Intra-cellular Therapies share price in Dollar and Rupees. Guide to invest in Intra-cellular Therapies from India. Also see the sentimental analysis on Indian investors investing in Intra-cellular Therapies. Get details on the Indian mutual funds that are investing in Intra-cellular Therapies. Get Analyst recommendations and forecasts along with all the Intra-cellular Therapies's financials.
Intra-cellular Therapies share price movements
- Today's Low: $83.06Today's High: $84.51
1.12%
Downside
Day's Volatility :1.72%
Upside
0.6%
- 52 Weeks Low: $62.7852 Weeks High: $93.45
25.26%
Downside
52 Weeks Volatility :32.82%
Upside
10.11%
Intra-cellular Therapies Returns
Intra-cellular Therapies Key Statistics
in dollars & INR
How to invest in Intra-cellular Therapies from India?
It is very easy for Indian residents to invest directly in Intra-cellular Therapies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Intra-cellular Therapies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Intra-cellular Therapies or ITCI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Intra-cellular Therapies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Intra-cellular Therapies shares which would translate to 0.010 fractional shares of Intra-cellular Therapies as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Intra-cellular Therapies, in just a few clicks!
Returns in Intra-cellular Therapies for Indian investors in Rupees
Investment Value
₹1,00,000
Intra-cellular Therapies investment value today
Current value as on today
₹1,20,167
Returns
₹20,167
(+20.17%)
Returns from Intra-cellular Therapies Stock
₹17,845 (+17.85%)
Dollar Returns
₹2,322 (+2.32%)
Indian investors sentiment towards Intra-cellular Therapies
Global Institutional Holdings in Intra-cellular Therapies
FMR Inc
10.49%
Vanguard Group Inc
9.08%
BlackRock Inc
5.96%
JPMorgan Chase & Co
4.99%
Wasatch Advisors LP
3.63%
venBio Select Advisor LLC
2.88%
Analyst Recommendation on Intra-cellular Therapies
Buy
86%Buy
13%Hold
0%Sell
Based on 23 Wall street analysts offering stock ratings for Intra-cellular Therapies(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Intra-cellular Therapies
What analysts predicted
Upside of 23.21%
Current:
$84.00
Target:
$103.50
Insights on Intra-cellular Therapies
Price Movement
In the last 3 years, ITCI stock has moved up by 62.6%Increasing Revenue
Revenue is up for the last 19 quarters, 882.51K → 175.15M (in $), with an average increase of 22.5% per quarterDecreasing Net Profit
Netprofit is down for the last 3 quarters, -15.24M → -26.32M (in $), with an average decrease of 34.3% per quarter
Intra-cellular Therapies Technicals Summary
Sell
Neutral
Buy
Intra-cellular Therapies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Intra-cellular Therapies Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -1.16% | 15.99% | 17.85% | 57.24% | 129.01% |
 | 7.77% | 1.41% | 4.42% | 62.14% | 26.9% |
 | 1.46% | 13.42% | 18.54% | 31.17% | 31.17% |
 | -8.07% | -2.2% | -15.97% | -33.36% | 23.49% |
 | -6.51% | 21.14% | 16.62% | -8.63% | -23.56% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -0.7 | -0.1 | -0.07 | NA | 10.8 |
| 36.53 | 36.53 | 0.32 | 6.37 | 0.16 | 0.12 | NA | 26.87 |
| 28.5 | 28.5 | 1.73 | 0.34 | 0.07 | 0.04 | 0.02 | 1.82 |
| 30.99 | 30.99 | 2.56 | 5.88 | 0.47 | 0.15 | 0.01 | 11.59 |
| 224.4 | NA | 0.08 | 2.69 | -0.04 | 0.02 | 0.04 | 16.58 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $8.9B | 129.01% | NA | -14.07% |
| Buy | $13.9B | 26.9% | 36.53 | 17.21% |
| Buy | $43.8B | 31.17% | 28.5 | 10.75% |
| Buy | $74.4B | 23.49% | 30.99 | 26.55% |
| Hold | $14.9B | -23.56% | 224.4 | -5.87% |
Intra-cellular Therapies Dividend announcements
Intra-cellular Therapies Earnings
Intra-cellular Therapies’s price-to-earnings ratio stands at None
Read More
About Intra-cellular Therapies
Management People of Intra-cellular Therapies
Important FAQs about investing in Intra-cellular Therapies from India :
What is Intra-cellular Therapies share price today?
Intra-cellular Therapies share price today stands at $84.00, Open: $83.86 ; Previous Close: $83.45 ; High: $84.51 ; Low: $83.06 ; 52 Week High: $93.45 ; 52 Week Low: $62.78. The stock opens at $83.86, after a previous close of $83.45. The stock reached a daily high of $84.51 and a low of $83.06, with a 52-week high of $93.45 and a 52-week low of $62.78.
Can Indians buy Intra-cellular Therapies shares?
Yes, Indians can invest in the Intra-cellular Therapies (ITCI) from India.
With INDmoney, you can buy Intra-cellular Therapies at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Intra-cellular Therapies at zero transaction cost.
How can I buy Intra-cellular Therapies shares from India?
It is very easy to buy Intra-cellular Therapies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Intra-cellular Therapies be purchased?
Yes, you can buy fractional shares of Intra-cellular Therapies with INDmoney app.
What are the documents required to start investing in Intra-cellular Therapies stocks?
To start investing in Intra-cellular Therapies, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Intra-cellular Therapies
Today’s highest price of Intra-cellular Therapies (ITCI) is $84.51.
Today’s lowest price of Intra-cellular Therapies (ITCI) is $83.06.
What is today's market capitalisation of Intra-cellular Therapies
What is the 52 Week High and Low Range of Intra-cellular Therapies
52 Week High
$93.45
52 Week Low
$62.78
What are the historical returns of Intra-cellular Therapies?
1 Month Returns
-1.16%
3 Months Returns
15.99%
1 Year Returns
17.85%
5 Years Returns
129.01%
